OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
Top Cited Papers
- 25 February 2026
- journal article
- Published by Springer Nature in Nature
- Vol. 652 (8110) , 740-751
Abstract
Chimeric antigen receptor (CAR)-natural killer (NK) cell therapies hold promise for solid tumours but remain limited because of poor tumour infiltration, persistence and resistance in the tumour microenvironment1-4. Here, to identify gain-of-function targets that enhance CAR-NK cell efficacy, we performed an unbiased in vivo CRISPR activation screen followed by a barcoded targeted in vivo open reading frame screen in primary human CAR-NK cells. We identified and comprehensively validated OR7A10, a G protein-coupled receptor (GPCR), as the top candidate. Engineering CAR-NK cells with OR7A10 cDNA (a CRISPR-independent method with a simple manufacturing strategy) enhanced their proliferation, activation, degranulation, cytokine production, death ligand expression, chemokine receptor expression, cytotoxicity, persistence, metabolic fitness and tumour microenvironment resistance. Moreover, exhaustion in primary human NK cells derived from multiple peripheral blood and cord blood donors was reduced. OR7A10 gain-of-function CAR-NK cells displayed strong in vivo efficacy across multiple solid tumour models. For example, 100% complete response with long-term tumour control and survival benefit in an orthotopic breast cancer mouse model were achieved. These findings establish OR7A10-engineered CAR-NK cells as a highly potent and scalable off-the-shelf therapeutic for solid tumours.Keywords
This publication has 79 references indexed in Scilit:
- Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3Journal of Biological Chemistry, 2015
- Identification and characterization of essential genes in the human genomeScience, 2015
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complexNature, 2014
- MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screensGenome Biology, 2014
- Oncogenic stress sensed by the immune system: role of natural killer cell receptorsNature Reviews Immunology, 2009
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genomeGenome Biology, 2009
- PID: the Pathway Interaction DatabaseNucleic Acids Research, 2008
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Functions of natural killer cellsNature Immunology, 2008
- Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.2001